Operating income increased 40.4%
Operating income changed +40.4% from the comparable as-filed period.
$195.9M→$275.0M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →VEEV financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 481 bp higher
Operating margin changed +481 basis points from the comparable as-filed period.
24.83%→29.64%3 prior comparisons
Net income increased 36.5%
Net income changed +36.5% from the comparable as-filed period.
$200.3M→$273.4M3 prior comparisons
Revenue increased 17.6%
Revenue changed +17.6% from the comparable as-filed period.
$789.1M→$928.0M3 prior comparisons
Gross profit increased 17.2%
Gross profit changed +17.2% from the comparable as-filed period.
$593.8M→$696.0M3 prior comparisons
Research & development increased 15.7%
Research & development changed +15.7% from the comparable as-filed period.
$192.7M→$222.9M3 prior comparisons
Cash & equivalents decreased 6.1%
Cash & equivalents changed -6.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.9B→$1.8B2 prior comparisons
Gross margin moved 26 bp lower
Gross margin changed -26 basis points from the comparable as-filed period.
75.26%→75.00%3 prior comparisons
Stock-based compensation increased 12.2%
Stock-based compensation changed +12.2% from the comparable as-filed period.
$122.0M→$136.8M3 prior comparisons
SBC / revenue moved 71 bp lower
SBC / revenue changed -71 basis points from the comparable as-filed period.
15.46%→14.74%3 prior comparisons
Operating margin moved 14 bp higher
Operating margin changed +14 basis points from the comparable as-filed period. The change ranks at the 7th percentile of 104 prior comparable changes.
30.79%→30.93%104 prior comparisons
Cash & equivalents decreased 3.5%
Cash & equivalents changed -3.5% from the comparable as-filed period. The change ranks at the 5th percentile of 223 prior comparable changes.
$2.0B→$1.9B223 prior comparisons
Stock-based compensation increased 6.3%
Stock-based compensation changed +6.3% from the comparable as-filed period. The change ranks at the 5th percentile of 104 prior comparable changes.
$112.2M→$119.3M104 prior comparisons
Revenue increased 16.3%
Revenue changed +16.3% from the comparable as-filed period. The change ranks at the 17th percentile of 104 prior comparable changes.
$759.0M→$882.9M104 prior comparisons
Research & development increased 13.2%
Research & development changed +13.2% from the comparable as-filed period. The change ranks at the 12th percentile of 104 prior comparable changes.
$184.0M→$208.3M104 prior comparisons
Operating income increased 16.8%
Operating income changed +16.8% from the comparable as-filed period. The change ranks at the 24th percentile of 104 prior comparable changes.
$233.7M→$273.1M104 prior comparisons
Net income increased 14.4%
Net income changed +14.4% from the comparable as-filed period. The change ranks at the 21th percentile of 104 prior comparable changes.
$228.2M→$260.9M104 prior comparisons
Gross profit increased 13.1%
Gross profit changed +13.1% from the comparable as-filed period. The change ranks at the 9th percentile of 104 prior comparable changes.
$585.2M→$662.0M104 prior comparisons
Gross margin moved 212 bp lower
Gross margin changed -212 basis points from the comparable as-filed period. The change ranks at the 60th percentile of 104 prior comparable changes.
77.10%→74.98%104 prior comparisons
Operating cash flow increased 28.5%
Operating cash flow changed +28.5% from the comparable as-filed period. The change ranks at the 56th percentile of 55 prior comparable changes.
$877.2M→$1.1B55 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.